https://www.neurologyadvisor.com/topics/alzheimers-disease-and-dementia/aducanumab-lecanemab-early-ad-clinical-trials-fda-approval/
These are the clinical trials that led to the FDA's approval of aducanumab and lecanemab for early AD, plus, the concerns that loom.
Create an account
or login to join the discussion